ATRYN ANTITHROMBIN (RECOMBINANT)

Serial Number 77713676
Registration 3748750
800

Registration Progress

Application Filed
Apr 14, 2009
Under Examination
Approved for Publication
Dec 1, 2009
Published for Opposition
Dec 1, 2009
Registered
Feb 16, 2010

Trademark Image

ATRYN ANTITHROMBIN (RECOMBINANT)

Basic Information

Serial Number
77713676
Registration Number
3748750
Filing Date
April 14, 2009
Registration Date
February 16, 2010
Published for Opposition
December 1, 2009
Renewal Date
February 16, 2020
Drawing Code
3000

Status Summary

Current Status
Active
Status Code
800
Status Date
Feb 14, 2020
Registration
Registered
Classes
005

Rights Holder

REVO BIOLOGICS, INC.

03
Address
175 CROSSING BOULEVARD
FRAMINGHAM, MA 01702

Ownership History

Lundbeck Inc.

Original Applicant
03
Deerfield, IL

Lundbeck Inc.

Owner at Publication
03
Deerfield, IL

Lundbeck Inc.

Original Registrant
03
Deerfield, IL

LUNDBECK INC.

New Owner After Registration #1
03
DEERFIELD, IL

LUNDBECK LLC

New Owner After Registration #2
16
DEERFIELD, IL

LUNDBECK LLC

New Owner After Registration #3
16
DEERFIELD, IL

REVO BIOLOGICS, INC.

New Owner After Registration #4
03
FRAMINGHAM, MA

Legal Representation

Attorney
Monte L. Falcoff/Jessica S. Sachs

USPTO Deadlines

Next Deadline
1520 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20100216)
Due Date
February 16, 2030
Grace Period Ends
August 16, 2030

Application History

38 events
Date Code Type Description Documents
Feb 14, 2020 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Feb 14, 2020 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Feb 14, 2020 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Feb 14, 2020 A7OK O AMENDMENT UNDER SECTION 7 - PROCESSED Loading...
Jan 3, 2020 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Nov 15, 2019 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Nov 14, 2019 ES7R I TEAS SECTION 7 REQUEST RECEIVED Loading...
Feb 16, 2019 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Aug 16, 2016 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Aug 16, 2016 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Apr 14, 2016 PR23 O POST REGISTRATION ACTION MAILED - SEC. 8 & 15 Loading...
Apr 12, 2016 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Feb 16, 2016 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Feb 16, 2015 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Aug 14, 2013 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Aug 7, 2013 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Mar 7, 2012 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Dec 7, 2011 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Apr 4, 2011 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 4, 2011 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 4, 2011 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 4, 2011 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 16, 2010 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 1, 2009 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 1, 2009 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 29, 2009 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Oct 29, 2009 ALIE A ASSIGNED TO LIE Loading...
Oct 15, 2009 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 23, 2009 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 22, 2009 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 22, 2009 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 29, 2009 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 29, 2009 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 29, 2009 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 29, 2009 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 18, 2009 MDSC O NOTICE OF DESIGN SEARCH CODE MAILED Loading...
Apr 17, 2009 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 17, 2009 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of [ infectious diseases, ] blood disorders [, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders ] ; Pharmaceutical preparations for the prevention and treatment of disorders of [ the nervous system, the immune system, ] the cardio-vascular system, the metabolic system [, the respiratory system, the musculo-skeletal system, the genitourinary system ] ; for the treatment of inflammatory disorders; for use [ in dermatology, oncology, ] hematology [ and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders ] ; Pharmaceutical preparations for the treatment of antithrombin deficiency; Pharmaceutical preparations, namely, anticoagulants
First Use Anywhere: Jan 1, 2009
First Use in Commerce: Jan 1, 2009

Additional Information

Design Mark
The mark consists of first line has the name "ATRYN" in dark blue with the "AT" being larger than the "RYN"; second line has "Antithrombin" in dark blue; third line has "Recombinant" in parenthesis in dark blue; beneath the "N" of "ATRYN", adjacent to lines two and three, is a representation of two plasmids resembling a figure "8". The overall color of the plasmids is green except that opposite sections of the plasmids appear in dark blue, representing the inserts.
Color Claim
The color(s) blue, green is/are claimed as a feature of the mark.
Other
Statement(s): The drawing is amended to appear as follows: PUBLISH NEW CUT

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"ANTITHROMBIN RECOMBINANT"